BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22517882)

  • 1. A baby step for nano.
    Tan S
    Sci Transl Med; 2012 Apr; 4(130):130fs8. PubMed ID: 22517882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine in cerebral palsy.
    Balakrishnan B; Nance E; Johnston MV; Kannan R; Kannan S
    Int J Nanomedicine; 2013; 8():4183-95. PubMed ID: 24204146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
    Kannan S; Dai H; Navath RS; Balakrishnan B; Jyoti A; Janisse J; Romero R; Kannan RM
    Sci Transl Med; 2012 Apr; 4(130):130ra46. PubMed ID: 22517883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. Nanoparticle treatment reverses cerebral palsy in rabbits.
    Miller G
    Science; 2012 Apr; 336(6079):286. PubMed ID: 22517832
    [No Abstract]   [Full Text] [Related]  

  • 5. [Using dendrimers for an innovative nanomedicine].
    Majoral JP
    Biol Aujourdhui; 2013; 207(1):61-70. PubMed ID: 23694726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic dendrimers: recent advances for catalysis, nanomaterials, and nanomedicine.
    Caminade AM
    Chem Soc Rev; 2016 Oct; 45(19):5174-86. PubMed ID: 26936375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedical applications of nano-antioxidant.
    Watal G; Watal A; Rai PK; Rai DK; Sharma G; Sharma B
    Methods Mol Biol; 2013; 1028():147-51. PubMed ID: 23740118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum concentration and daily dose of dantrolene in cerebral palsy patients.
    Inotsume N; Higashi A; Matsukane I; Chikazawa S; Nakano M; Matsuda I
    Pediatr Pharmacol (New York); 1986; 5(4):253-9. PubMed ID: 3737270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with botulinum toxin in the treatment of cerebral palsy.
    Arens LJ; Leary PM; Goldschmidt RB
    S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen and motor function in cerebral palsy.
    Krach L
    Dev Med Child Neurol; 2011 May; 53(5):391. PubMed ID: 21480871
    [No Abstract]   [Full Text] [Related]  

  • 11. More than Just Size: Challenges and Opportunities of Hybrid Dendritic Nanocarriers.
    Rimondino GN; Oksdath-Mansilla G; Brunetti V; Strumia MC
    Curr Pharm Des; 2017; 23(21):3142-3153. PubMed ID: 28403793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of families of children with cerebral palsy of the "CP-graph on treatment modalities for gross motor function".
    Papavasiliou AS; Ioannou J; Gavatha M; Nikaina I; Rizou I
    Eur J Paediatr Neurol; 2012 Nov; 16(6):762-3. PubMed ID: 22483444
    [No Abstract]   [Full Text] [Related]  

  • 13. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 14. Methocarbamol in the treatment of cerebral palsy in children.
    Bjerre I; Blennow G
    Neuropadiatrie; 1971 Oct; 3(2):140-6. PubMed ID: 4947731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intrathecal Baclofen Therapy for Cerebral Palsy].
    Kishima H
    No Shinkei Geka; 2015 Aug; 43(8):681-90. PubMed ID: 26224461
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K; Forsberg A
    Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.
    Nance E; Zhang F; Mishra MK; Zhang Z; Kambhampati SP; Kannan RM; Kannan S
    Biomaterials; 2016 Sep; 101():96-107. PubMed ID: 27267631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Motor test in cerebral palsy treated with methocarbamol].
    Bjerre I; Blennow G
    Lakartidningen; 1972 Oct; 69(44):5074-6. PubMed ID: 5076834
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs in cerebral palsy.
    Drug Ther Bull; 1965 Nov; 3(23):89-90. PubMed ID: 5839739
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebral palsy and the use of suxamethonium.
    Sigston PE; Gill CP; Jackson EA
    Br J Hosp Med; 1995 Oct 4-17; 54(7):354. PubMed ID: 8556218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.